Allergy & Immunology  
The MD Magazine Allergy & Immunology condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Sponsored

Researchers sought to develop a method of identifying disease risk for asthma across via genetic markers.
Data determined an increased need for asthma education at home for low-income and minority families of children with asthma.
Michael Wechsler, MD, MMSc, recounts the phase III trial of Mepolizumab on patients with eosinophilic granulomatosis with polyangiitis (EGPA).
Drug meets all primary and secondary end points in phase III study.
Benralizumab led to a 75% reduction in the use of oral corticosteroids for severe asthma.
Asthma patients woke up less often and improved faster with FF/VI
LAIV was associated with a decreased risk of asthma exacerbation.
CDC task force has recommended not using LAIV (nasal spray) for influenza prevention.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$